De novo minimal change disease after ABO-incompatible kidney transplantation

Clinical Transplantation

Volumn 26, Issue SUPPL.24, 2012, Pages 81-85

  Mochizuki, Yasushi ^a   Iwata, Takahisa ^a   Nishikido, Masaharu ^b   Uramatsu, Tadashi ^b   Sakai, Hideki ^a   Taguchi, Takashi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

De novo; Kidney transplantation; Minimal change disease; Nephrotic syndrome

Indexed keywords

CYCLOSPORIN A; GLUCOSE; INSULIN; METHYLPREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CASE REPORT; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG PULSE THERAPY; ELECTRON MICROSCOPY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MICROSCOPY; MINIMAL CHANGE DISEASE; NEPHROTIC SYNDROME; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; REMISSION; STEROID THERAPY;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUP INCOMPATIBILITY; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; PROTEINURIA;

EID: 84863215354     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2012.01645.x     Document Type: Article

References (14)

1. Peddi VR, Dean DE, Hariharan S, Cavallo T, Schroeder TJ, First MR Proteinuria following renal transplantation: correlation with histology and outcome. Transplant Proc 1997: 29: 101.
2. Perez Fontan M, Rodriguez-Carmana A, Garcia Falcon T, Valdes F Early proteinuria in renal transplant recipients treated with cyclosporin. Transplantation 1999: 67: 561.
3. Yakupoglu U, Baranowska-Daca E, Rosen D, Barrios R, Suki WN, Truong LD Post-transplant nephrotic syndrome: a comprehensive clinicopathological study. Kidney Int 2004: 65: 2360.
4. Ramanathan V, Suki WN, Rosen D, Truong LD Chronic allograft nephropathy and nephrotic range proteinuria. Clin Transplant 2005: 19: 413.
5. Markowitz GS, Stemmer CL, Crroker BP, D'agati VD De novo minimal change disease. Am J Kidney Dis 1998: 32: 508.
6. First MR, Vaidya PN, Maryniak RK et al. Proteinuria following transplantation. Correlation with histopathology and outcome. Transplantation 1984: 38: 607.
7. Cheigh JS, Mouradian J, Susin M et al. Kidney transplant nephrotic syndrome: relationship between allograft histopathology and natural course. Kidney Int 1980: 18: 358.
8. Zafarmand AA, Baranowska-Daca E, Ly PDC et al. De novo minimal change disease associated with reversible post-transplant nephrotic syndrome. A report of five cases and review of literature. Clin Transplant 2002: 16: 350.
9. Olson JL, Schwartz MM The nephrotic syndrome: minimal change disease, focal segmental glomerulosclerosis, and miscellaneous causes. In: Jennette V, Olson JL, Schwartz MM, Silva FG eds. Heptinstall's Pathology of the Kidney, 5th edn. Philadelphia, PA: Lippincott-Raven, 1998: 200, 208.
10. Audard V, Pardon A, Claude O et al. Necrotizing fasciitis during de novo minimal change nephrotic syndrome in a kidney transplant recipient. Transpl Infect Dis 2005: 7: 89.
11. Mainra R, Mulay A, Bell R et al. Sirolimus use and de novo minimal change nephrology following renal transplantation. Transplantation 2005: 80: 1816.
12. Vincenti F, Ghiggeri GM New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant 2005: 5: 1179.
13. Salvin VJ, Sharma R, Sharma M et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Eng J Med 1996: 334: 878.
14. Madhan KK, Temple-Camp CR Late de novo minimal change disease in a renal allograft. Saudi J Kidney Dis Transpl 2009: 20: 266.